Hoth Therapeutics pulls in $3 mln Series A [Reuters]
SPHERIX (SPEX)
US:NASDAQ Investor Relations:
spherix.com/investors.php
Company Research
Source: Reuters
Hoth Therapeutics pulls in $3 mln Series A - PE Hub US Edition (daily) Canada Edition (weekly) I accept the Terms and Conditions New York City-based Hoth Therapeutics , a biopharmaceutical company focused on treating patients suffering from ailments such as atopic dermatitis, has raised $3 million in Series A funding. The investors were not named. Laidlaw & Co (UK) Ltd was the placement agent. PRESS RELEASE NEW YORK, Feb. 22, 2018 /PRNewswire/ — Hoth Therapeutics Inc. (“Hoth” or the “Company”), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema, announced today that it has completed its Series A financing totaling $3 million, before expenses, to fund operations and advance Hoth’s BioLexa Platform. Laidlaw & Co (UK) Ltd. (“Laidlaw”) in New York served as the sole placement agent. Robb Knie, Hoth CEO stated, “We are extremely pleased to have completed this
Show less
Read more
Impact Snapshot
Event Time:
SPEX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SPEX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SPEX alerts
High impacting SPHERIX news events
Weekly update
A roundup of the hottest topics